  | Gofflot, A., Dupont, M., Bernard, B., Croisier, J.-L., Forthomme, B., MONIN, L., BOUTAFFALA, L., Otte, T., Louis, E., & Vieujean, S. (02 April 2025). Développement et validation d'un outil évaluant les facteurs limitant l'activité physique des patients atteints de maladie inflammatoire chronique de l'intestin.10ème journées francophones de kinésithérapie [Poster presentation]. 10èmes journées francophones de kinésithérapie, Montpellier, France.  Peer reviewed |
 | Meuwis, M.-A., Baiwir, D., Fleron, M., Mazzucchelli, G., BOUTAFFALA, L., Reenaers, C., Van Kemseke, C., Vieujean, S., Bettonville, V., BRIQUET, A., Lechanteur, C., COIMBRA MARQUES, C., & Louis, E. (21 February 2025). Perianal Fistula Closure after Heterologous Mesenchymal Stem Cell Injections is Associated with Protein Levels indicating Lower Tissue Immune Infiltrate, Specific Proteins Involved in the Control of Apoptosis, and Probable Higher Tissues Remodeling and Proteasome Activity [Poster presentation]. 20th Congress of European Crohn's and Colitis Organisation, Berlin, Germany. Peer reviewed |
Meuwis, M.-A., Baiwir, D., Fleron, M., Mazzucchelli, G., BOUTAFFALA, L., Reenaers, C., Van Kemseke, C., Vieujean, S., Bettonville, V., BRIQUET, A., LECHANTEUR, C., COIMBRA MARQUES, C., & Louis, E. (12 February 2025). Perianal fistula closure after heterologous mesenchymal stem cell injections is associated with protein levels indicating lower tissue immune infiltrate, specific proteins involved in the control of apoptosis, and probable higher tissues remodeling and proteasome activity [Poster presentation]. 37th edition of Belgian Week of Gastroenterology. Peer reviewed |
 | Reenaers, C., GILLARD, R., Coimbra, C., Vieujean, S., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2024). MRI Evolution And Efficacy Of Bone Marrow-Derived Mesenchymal Stem Cells In Perianal Fistulae In Crohn’s Disease: Results From A Prospective Monocentric Study [Poster presentation]. UEG Week Vienna 2022. Peer reviewed |
  | Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192 Peer Reviewed verified by ORBi |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., BOUTAFFALA, L., GILLARD, R., Meunier, P., & Louis, E. (March 2022). Efficacité et sécurité du traitement par cellules souches mésenchymateuses hématopoïétiques dans les lésions ano-périnéales de maladie de Crohn : résultats d’une étude prospective monocentrique [Paper presentation]. Journées Francophones D’hépato-Gastroenterologie Et D’oncologie Digestive. Peer reviewed |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (March 2022). Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn's disease: results from a prospective monocentric study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. Peer reviewed |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 Peer Reviewed verified by ORBi |
 | Reenaers Dr, C., Vieujean, S., Coimbra, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (01 January 2022). DOP31 Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric study [Paper presentation]. 17th Congress of European Crohn's and Colitis Organisation. doi:10.1093/ecco-jcc/jjab232.070 Peer reviewed |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology. Peer reviewed |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., Pariente, B., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & LOUIS, E. (July 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. Peer reviewed |
| Boutaffala, L. (2013). New pro-death function of NIK downstream of TNFR1 [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/142271 |
 | Remacle, C., Cline, S., Boutaffala, L., Gabilly, S., Larosa, V., Barbieri, M. R., Coosemans, N., & Hamel, P. P. (2009). The ARG9 Gene Encodes the Plastid-Resident N-Acetyl Ornithine Aminotransferase in the Green Alga Chlamydomonas reinhardtii. Eukaryotic Cell, 8 (9), 1460-1463. doi:10.1128/EC.00108-09 Peer Reviewed verified by ORBi |
 | Cardol, P., Boutaffala, L., Memmi, S., Devreese, B., Matagne, R.-F., & Remacle, C. (16 January 2008). In Chlamydomonas, the Loss of Nd5 Subunit Prevents the Assembly of Whole Mitochondrial Complex I and Leads to the Formation of a Low Abundant 700 Kda Subcomplex. Biochimica et Biophysica Acta. Bioenergetics, 1777, 388-396. doi:10.1016/j.bbabio.2008.01.001 Peer Reviewed verified by ORBi |
 | Larosa, V., Remacle, C., Cline, S., Boutaffala, L., Gabilly, S., & Hamel, P. (2008). Relocating the Nuclear Gene for Acetylornithine Aminotransferase (ARG9) to the Chloroplast in the Green Alga Chlamydomonas reinhardtii [Poster presentation]. 10th Annual symposium of the plant molecular biology and biotechnology research, Columbus - Ohio, United States. |
